Test Price
2,800 AED✅ Home Collection Available
DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation by a DHA‑licensed genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This NGS‑based genetic test analyses the entire coding region of the DNAL1 gene to confirm primary ciliary dyskinesia type 16, a rare ciliopathy causing chronic otosinopulmonary infections and impaired mucociliary clearance. Next Generation Sequencing provides comprehensive coverage with analytical sensitivity exceeding 99.9%.
| Feature | Our Test (DNAL1 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | Full gene coverage, >99.9% analytical sensitivity & specificity | Targeted exons only; may miss deep intronic variants |
| Methodology | NGS (Next Generation Sequencing, Illumina NovaSeq X Plus) | Capillary electrophoresis‑based Sanger sequencing |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I understand that the diagnostic journey for primary ciliary dyskinesia can be emotionally demanding. This high‑precision NGS assay offers molecular confirmation, enabling early, personalised respiratory management. Always correlate genetic findings with clinical and electron microscopy data for a complete picture.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Note & Medication Warning
⚠ Medication Warning: Do not discontinue any prescribed medication without consulting your treating physician. This test does not replace clinical evaluation.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Active severe respiratory infection requiring hospitalisation; inability to provide blood/DNA sample; non‑consenting minors (under UAE Federal Law No. 2 of 2019 concerning health ICT, patient consent required).
- Red Flags – Seek Emergency Care Immediately: Sudden severe breathlessness, cyanosis, high fever unresponsive to antipyretics, or chest pain.
Patient FAQ & Clinical Guidance
1. What is the DNAL1 gene and how does it relate to primary ciliary dyskinesia type 16?
The DNAL1 gene encodes a dynein axonemal light chain essential for outer arm assembly; mutations disrupt ciliary beat, causing chronic sinopulmonary infections and laterality defects.
2. How is the performed and what sample is required?
A simple blood draw, extracted DNA, or a single drop of blood on an FTA card is collected by our DHA‑licensed phlebotomy team during a scheduled home visit.
3. When will I get my results and will a genetic counsellor explain them?
Results are available within 3–4 weeks; every report includes a telephonic consultation with a DHA‑licensed genetic counsellor who explains findings, inheritance risks, and next steps.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance: This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient clinical data is encrypted, access‑controlled, and used solely for diagnostic purposes with explicit consent. Furthermore, clinical testing safety and patient consent adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | DNAL1 Gene Primary Ciliary Dyskinesia Type 16 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (or extracted DNA / FTA card) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM. |
| Methodology Used | Next Generation Sequencing (Illumina NovaSeq X Plus) |
| ICD-10-CM Code | J98.09 (Primary ciliary dyskinesia, unspecified) |
| LOINC Code | 94222-1 (DNA sequence analysis of gene panel for inherited disorder) |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians